Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 21.84B P/E 28.95 EPS this Y - Ern Qtrly Grth -33.70%
Income 1.11B Forward P/E - EPS next Y - 50D Avg Chg 9.00%
Sales 16.4B PEG - EPS past 5Y - 200D Avg Chg -6.00%
Dividend 9.00% Price/Book 0.24 EPS next 5Y - 52W High Chg -29.00%
Recommedations - Quick Ratio 0.71 Shares Outstanding 0.99B 52W Low Chg 120.00%
Insider Own - ROA 4.02% Shares Float 198.70M Beta 0.61
Inst Own 0.01% ROE 6.22% Shares Shorted/Prior -/- Price 22.00
Gross Margin 78.60% Profit Margin 6.76% Avg. Volume 1,786 Target Price -
Oper. Margin 13.64% Earnings Date - Volume 7,539 Change 0.00%
About H.LUNDBECK A/S SPON ADR EA REPR

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

HLUYY Chatroom

User Image Burningsmoke Posted - 11/26/23

$CYBN big week for Cybin coming up as they publish there phase 2 Top-line Results hopefully this is what they need to see some big pharma action $PFIZER.NSE $GSK $HLUYY $ https://www.businesswire.com/news/home/20231120171066/en/Cybin-to-Host-CYB003-Topline-Depression-Study-Review-and-RD-Briefing-on-November-30-2023-in-New-York-City

User Image Investnoobie Posted - 07/20/23

$FSRNQ my top 5 $FSRNQ $IFX $BAM $SVNLY $HLUYY

User Image risenhoover Posted - 1 year ago

$HLUYY HLUYY / H. Lundbeck A/S Price Target Updated https://fintel.io/sfo/us/hluyy

User Image MarketBeat Posted - 01/23/23

H. Lundbeck A/S initiated by Citigroup Inc. at neutral. www.marketbeat.com/stocks/OTCMKTS/HLUYY/price-target/ $HLUYY

User Image MarketBeat Posted - 1 year ago

H. Lundbeck A/S downgraded by JPMorgan Chase & Co. to neutral. https://www.marketbeat.com/r/1868379 $HLUYY

User Image MarketBeat Posted - 1 year ago

H. Lundbeck A/S's PT cut by UBS Group AG to 28.00. https://www.marketbeat.com/r/1861321 $HLUYY

User Image MarketBeat Posted - 2 years ago

H. Lundbeck A/S's PT cut by Deutsche Bank Aktiengesellschaft to 31.00. hold rating. https://www.marketbeat.com/r/1854066 $HLUYY

User Image MarketBeat Posted - 2 years ago

H. Lundbeck A/S downgraded by Credit Suisse Group AG to neutral. https://www.marketbeat.com/r/1819003 $HLUYY

User Image Masonato Posted - 2 years ago

$HLUYY why has this Lundbeck stock ticker stopped trading? It stopped on August 9, 2022 with no notification. Does anyone have a press release from the company concerning HLUYY? JPMorgan placed a target price on the stock at $43.00 on August 20, 2022.

User Image MarketBeat Posted - 08/19/22

H. Lundbeck A/S's PT cut by JPMorgan Chase & Co. to 43.00. https://www.marketbeat.com/r/1810864 $HLUYY

User Image Stock_Titan Posted - 2 years ago

$HLUYY Otsuka Pharmaceutical and Lundbeck present positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole at the 2022 Alzheimer's Association International Conference https://www.stocktitan.net/news/HLUYY/otsuka-pharmaceutical-and-lundbeck-present-positive-results-showing-t1annw2ton6v.html

User Image Stock_Titan Posted - 2 years ago

$HLUYY Otsuka Pharmaceutical and Lundbeck to Present Phase 3 Data for Brexpiprazole in Patients with Alzheimer’s Dementia at AAIC 2022 https://www.stocktitan.net/news/HLUYY/otsuka-pharmaceutical-and-lundbeck-to-present-phase-3-data-for-1ngybnrs89ph.html

User Image MarketBeat Posted - 2 years ago

H. Lundbeck A/S's PT raised by UBS Group AG to 35.00. https://www.marketbeat.com/r/1791495 $HLUYY

User Image STCKPRO Posted - 2 years ago

$HLUYY NEW ARTICLE : Lundbeck Gets A Much-Needed Win, But The Investment Case Is Still Not Clear-Cut https://www.stck.pro/news/HLUYY/31198506

User Image Masonato Posted - 2 years ago

$PFE Have you checked out Lundbeck Pharma lately? $HLUYY 👀📈💰

User Image dividendinvestorbyeagle Posted - 2 years ago

$HLUYY close increased > 10% (ADR (Sponsored) Level 1/H. Lundbeck A/S (Denmark)) https://www.dividendinvestor.com/dividend-news/?symbol=hlu

User Image MarketBeat Posted - 2 years ago

H. Lundbeck A/S upgraded by Deutsche Bank Aktiengesellschaft to hold. https://www.marketbeat.com/r/1788172 $HLUYY

User Image MarketBeat Posted - 2 years ago

H. Lundbeck A/S's PT cut by Barclays PLC to 44.00. overweight rating. https://www.marketbeat.com/r/1786968 $HLUYY

User Image MarketBeat Posted - 2 years ago

H. Lundbeck A/S's PT raised by JPMorgan Chase & Co. to 46.00. overweight rating. https://www.marketbeat.com/r/1785855 $HLUYY

User Image dividendinvestorbyeagle Posted - 06/30/22

$HLUYY close decreased > 10% (ADR (Sponsored) Level 1/H. Lundbeck A/S (Denmark)) https://www.dividendinvestor.com/dividend-news/?symbol=hlu

User Image dividendinvestorbyeagle Posted - 06/28/22

$HLUYY close increased > 10% (ADR (Sponsored) Level 1/H. Lundbeck A/S (Denmark)) https://www.dividendinvestor.com/dividend-news/?symbol=hlu

User Image JoeSpringer Posted - 06/27/22

$SAVA's MOA gets further bolstered by Montreal Filamin study And $HLUYY Alzheimer's agitation drug looks good Noon EST stream, watch / like / join: https://youtu.be/ESswQV5iz6c $CMPS $IBB $XBI

User Image Stock_Titan Posted - 06/27/22

$HLUYY Otsuka Pharmaceutical and Lundbeck Announce Positive Results Showing Reduced Agitation in Patients with Alzheimer’s Dementia Treated with Brexpiprazole https://www.stocktitan.net/news/HLUYY/otsuka-pharmaceutical-and-lundbeck-announce-positive-results-showing-89d96latb95j.html

User Image EarningsInsider Posted - 2 years ago

SVB Leerink Lowers H. Lundbeck A/S Q2 2022 Earnings Estimates to $0.55 EPS (Previously $0.56). https://www.marketbeat.com/x/1240783 $HLUYY

User Image EarningsInsider Posted - 2 years ago

SVB Leerink Lowers H. Lundbeck A/S Q2 2022 Earnings Estimates to $0.56 EPS (Previously $0.67). https://www.marketbeat.com/x/1239484 $HLUYY

User Image EarningsInsider Posted - 2 years ago

SVB Leerink Sets H. Lundbeck A/S FY2026 Earnings Estimates at $3.91 EPS. https://www.marketbeat.com/x/1237649 $HLUYY

User Image EarningsInsider Posted - 04/25/22

SVB Leerink Raises H. Lundbeck A/S FY2022 Earnings Estimates to $2.16 EPS (Previously $1.97). https://www.marketbeat.com/x/1223672 $HLUYY

User Image EarningsInsider Posted - 04/22/22

SVB Leerink Raises H. Lundbeck A/S Q1 2022 Earnings Estimates to $0.58 EPS (Previously $0.51). https://www.marketbeat.com/x/1222583 $HLUYY

User Image dividendinvestorbyeagle Posted - 03/29/22

$HLUYY div. rate decreased > 3% (ADR (Sponsored) Level 1/H. Lundbeck A/S (Denmark)) https://www.dividendinvestor.com/dividend-news/?symbol=

User Image fda_tracker Posted - 03/24/22

$HLUYY Phase 3 trial w/est Mar completion date NCT03548584: http://clinicaltrials.gov/ct2/show/NCT03548584 Trial Tracker: https://www.fdatracker.com/trial-tracker/

Analyst Ratings
Leerink Swann Market Perform Nov 13, 18